Lipocine Reports Presentation of LPCN 1021 Data at SMSNA Meeting

Lipocine Inc. LPCN, a specialty pharmaceutical company, today announced that clinical data for LPCN 1021, an oral testosterone product candidate for testosterone replacement therapy ("TRT") in adult males for conditions associated with a deficiency or absence of endogenous testosterone ("hypogonadism"), will be presented at the 21st Annual Meeting of the Sexual Medicine Society of North America (SMSNA) in Las Vegas, NV. Presentation/poster details are as follows: Title: Dose Titration and Safety of Oral Testosterone (LPCN 1021) in Hypogonadal Men: Results from the SOAR Study (#030) Date: November 20th Time: 3:15 pm PST (Poster: 3:00 - 4:00 pm PST) Presenter: Mohit Khera, MD Associate Professor, Urology Baylor College of Medicine Houston, TX, US Director, Laboratory for Andrology Research Medical Director, Houston Hospital for Specialized Surgery Title: Assessment of Fasting and Varying Meal Fat Content on the Bioavailability of Testosterone from Oral Testosterone Undecanoate (LPCN 1021) in Hypogonadal Men (#036) Date: November 20th Time: 3:45 pm PST (Poster: 3:00 - 4:00 pm PST) Presenter: Mohit Khera, MD Title: Efficacy and Pharmacokinetics of Oral Testosterone (LPCN 1021) in Hypogonadal Men (#028) Date: November 20th Time: 3:05 pm PST (Poster: 3:00 - 4:00 pm PST) Presenter: Irwin Goldstein, MD Director, San Diego Sexual Medicine Director, Sexual Medicine, Alvarado Hospital, San Diego, CA Clinical Professor of Surgery, University of California at San Diego Editor-in-Chief, Sexual Medicine Reviews President-Elect, International Society for the Study of Women's Sexual Health Editor Emeritus, The Journal of Sexual Medicine Editor Emeritus, International Journal of Impotence Research
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!